3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
38
Neoplasm Metastasis
16
Leukemia, Myeloid, Acute
13
Skin Neoplasms
10
Kidney Neoplasms
10
Leukemia
9
Carcinoma, Renal Cell
9
Neoplasms
7
Ovarian Neoplasms
6
Breast Neoplasms
6
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Congenital Abnormalities
4
Neuroblastoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Recurrence
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Interventions
Sunitinib
2
Paclitaxel
2
valrubicin
1
temsirolimus
1
sipuleucel-T
1
luprolide acetate gel depot
1
ferumoxtran-10
1
abiraterone
1
abemaciclib
1
Suspensions
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Powders
1
Pemetrexed
1
Neoadjuvant Therapy
1
National Cancer Institute (U.S.)
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Leuprolide
1
Fatty Acids, Omega-3
1
Educational Status
1
Docetaxel
1
Bevacizumab
1
Atorvastatin
1
Administration, Intravesical
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urogenital Neoplasms
×
Interleukin-2
×
Clear all
No trials found.